Show simple item record

dc.contributoren-US
dc.creatorMichelino, Francesca
dc.creatorCaputo, Mauro
dc.creatorCammarano, Antonello
dc.creatorLamberti, Emilia
dc.date2014-09-24
dc.date.accessioned2019-05-03T13:21:44Z
dc.date.available2019-05-03T13:21:44Z
dc.identifierhttps://www.jotmi.org/index.php/GT/article/view/1540
dc.identifier10.4067/S0718-27242014000300005
dc.identifier.urihttp://revistaschilenas.uchile.cl/handle/2250/87080
dc.descriptionThe aim of the paper is to analyse the relationships between the openness degree of companies and their 1) context features, 2) R&D organization and 3) financial performances. The openness degree is defined after a pecuniary approach, involving all the transactions in the innovation market. Hypotheses are formulated and, then, tested on a sample of 126 world top R&D spending bio-pharmaceutical companies for the period 2008-2012. Open innovation is more pervasive among small and young companies, for most of which it represents the very core business. Inbound and outbound practices have a similar diffusion in terms of number of companies adopting them, but the cumulative values of inbound flows are higher, whereas outbound flows are more relevant when compared to the total business of the firms. Inbound practices are substitutive to internal R&D activities, while outbound ones are complementary to internal development. The performances of companies have an inverted-U shape trend versus inbound practices and a fundamentally decreasing trend versus outbound ones.en-US
dc.formatapplication/pdf
dc.languageeng
dc.publisherFacultad de Economía y Negocios, Universidad Alberto Hurtadoen-US
dc.relationhttps://www.jotmi.org/index.php/GT/article/view/1540/922
dc.rightsCopyright (c) 2014 Journal of Technology Management & Innovationen-US
dc.rightshttp://creativecommons.org/licenses/by/4.0en-US
dc.sourceJournal of Technology Management & Innovation; Vol 9, No 3 (2014); 65-82en-US
dc.sourceJournal of Technology Management & Innovation; Vol 9, No 3 (2014); 65-82es-ES
dc.source0718-2724
dc.subjectOpen innovation; Inbound open innovation; Outbound open innovation; R&D organization; Financial performances; Bio-pharmaceutical industry.en-US
dc.titleInbound and Outbound Open Innovation: Organization and Performancesen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeArtículo revisado por paresen-US


This item appears in the following Collection(s)

Show simple item record